source
- Corxel to go public via $300 million SPAC merger, advancing GLP-1 pill CX11 and amylin candidateCorxel Pharmaceuticals announced it will become a public company by merging with the SPAC Amanat Acquisition Corp., accompanied by a $300 million private investment. The transaction will fund the…
- Patient dies after receiving Bristol Myers experimental autoimmune CAR-T therapy zola-celA participant in Bristol Myers Squibb’s multiple sclerosis trial died 44 days after being infused with the experimental cell therapy known as zola-cel. The company disclosed that the patient develo…